Camden Hepatitis C Pathway
This pathway has been developed from published guidance, in collaboration with local
hepatologists.
This guidance is to assist GPs in decision making and is not intended to replace clinical
judgment.
Newly diagnosed Hepatitis C RNA positive patient
Notify PHE North East
and North Central
London Health
Protection Team
nencl.hpu@nhs.net
Tel: 020 3837 7084
(option 1)
Fax: 020 3837 7086
References
https://cks.nice.org.uk/hepatitis-c
Comments & enquiries relating to medication:
CCCG Medicines Management Team
mmt.camdenccg@nhs.net
Clinical Contact for pathway queries:
Camden.pathways@nhs.net
Patient Info HCV antibody positive patient discharged post
successful treatment (RNA negative)
British Liver Trust
Hepatitis C Trust
Offer hepatitis A & B testing and Offer hepatitis A &
vaccination if not immune B vaccination
Think at risk groups:  Annual review for 5
Offer lifestyle advice regarding unprotected sex, drug years for Chronic Liver
paraphernalia, alcohol, tattooing and piercing. Advise Pregnant women – inform antenatal care Disease
against donating blood, carrying donor organ card,  FBC, LFTs, AFP
sharing razors/toothbrushes etc. Healthcare workers – advise patient to speak
to occupational health if taking part in
Exposure prone procedures (EPP)
If abnormal LFT – check
HCV RNA
 FBC, INR
 AFP, LFT’s (inc AST and ALT), TFTs
 HCV RNA viral load
 HIV (offer)
 (Ultrasound Liver scan)
 (HCV Genotype) HCV RNA positive HCV RNA positive
Consider urgent referral if
 US demonstrates HCC
 ALT> 300
 Evidence of decompensated liver disease
i.e. ascites/ encephalopathy, jaundice
Follow abnormal LFT
pathway
Refer to secondary care
Document co-morbidities. Attach all blood and
US scan results
Pathway created by NCL
Approved by Camden CCG Clinical
Cabinet + GB July 2016
Review due – March 2020